Therefore, we measured the distribution of CD4+ T, CD8+ T, and activated CD8+ T cells (CD69+CD8+) in peripheral blood, sentinel lymph nodes, and tumor-bedding sites (Supplementary Fig. 4). The gene discussed is CD69; the disease is neoplasm.